Clinisciences > VCAM1 Antibody
VCAM1 Antibody
Référence OAEE00595
Conditionnement : 100tests(T100)
Marque : Aviva Systems Biology
| Datasheets/Manuals | Printable datasheet for VCAM1 Antibody |
|---|
| Predicted Species Reactivity | Human |
|---|---|
| Product Format | Stabilizing phosphate buffered saline (PBS), pH 7.4, 15 mM sodium azide |
| Clonality | Monoclonal |
| Clone | STA |
| Isotype | IgG1 |
| Host | Mouse |
| Conjugation | APC |
| Application | FC |
| Reconstitution and Storage | 2°C to 8°C |
| Immunogen | Human DS6 T cell line |
| Purification | Purified by size-exclusion chromatography |
| Concentration | 10 ul / test |
| Specificity | The mouse monoclonal antibody STA recognizes CD106 antigen (VCAM-1), a 100-110 kDa type I membrane protein of the immunoglobulin superfamily, a crucial mediator of leukocyte adhesion, and a costimulation molecule. HLDA V; WS Code A013 |
| Formulation | APC |
| Storage Buffer | The reagent is provided in phosphate buffered saline (PBS) containing 15 mM sodium azide and 0.2% (w/v) high-grade protease free Bovine Serum Albumin (BSA) as a stabilizing agent. |
| Reference | Yen YT, Liao F, Hsiao CH, Kao CL, Chen YC, Wu-Hsieh BA: Modeling the early events of severe acute respiratory syndrome coronavirusinfection in vitro. J Virol. 2006 Mar;80(6):2684-93. Leca G, Mansur SE, Bensussan A: Expression of VCAM-1 (CD106) by a subset of TCR gamma delta-bearing lymphocyte clones. Involvement of a metalloprotease in the specific hydrolytic release of the soluble isoform. J Immunol. 1995 Feb 1;154(3):1069-77. Leukocyte Typing V., Schlossman S. et al. (Eds.), Oxford University Press (1995). Paessens LC, Singh SK, Fernandes RJ, van Kooyk Y: Vascular cell adhesion molecule-1 (VCAM-1) and intercellular adhesion molecule-1 (ICAM-1) provide co-stimulation in positive selection along with survival ofselected thymocytes. Mol Immunol. 2008 Jan;45(1):42-8. Postadzhiyan AS, Tzontcheva AV, Kehayov I, Finkov B: Circulating soluble adhesion molecules ICAM-1 and VCAM-1 and their association with clinical outcome, troponin T and C-reactive protein in patients with acutecoronary syndromes. Clin Biochem. 2007 Sep 19 Wu TC: The role of vascular cell adhesion molecule-1 in tumor immune evasion. Cancer Res. 2007 Jul 1;67(13):6003-6. van Wetering S, van den Berk N, van Buul JD, Mul FP, Lommerse I, Mous R, ten Klooster JP, Zwaginga JJ, Hordijk PL: VCAM-1-mediated Rac signaling controls endothelial cell-cell contacts and leukocyte transmigration. Am J Physiol Cell Physiol. 2003 Aug;285(2):C343-52. |
|---|---|
| Gene Symbol | VCAM1 |
| Gene Full Name | vascular cell adhesion molecule 1 |
| Alias Symbols | CD106, CD106 antigen, INCAM-100, vascular cell adhesion protein 1. |
| NCBI Gene Id | 7412 |
| Protein Name | Vascular cell adhesion protein 1 |
| Description of Target | Important in cell-cell recognition. Appears to function in leukocyte-endothelial cell adhesion. Interacts with integrin alpha-4/beta-1 (ITGA4/ITGB1) on leukocytes, and mediates both adhesion and signal transduction. The VCAM1/ITGA4/ITGB1 interaction may play a pathophysiologic role both in immune responses and in leukocyte emigration to sites of inflammation. |
| Uniprot ID | P19320 |
| Protein Accession # | NP_001069.1; NP_001186763.1; NP_542413.1 |
| Nucleotide Accession # | NM_001078.3; NM_001199834.1; NM_080682.2 |
Protein interactions
| Name | # of Products |
|---|---|
| CCL17 | 26 |
| CCL22 | 30 |
| CTSG | 148 |
| ELANE | 169 |
| EZR | 276 |
| IL13 | 15 |
| ITGAD | 42 |
| ITGB1 | 292 |
| ITGB7 | 65 |
| MSN | 157 |
| SEC61B | 35 |
| VCAM1 | 51 |
Biological pathways
| Name | # of Products |
|---|---|
| B cell differentiation | 158 |
| Heterophilic cell-cell adhesion | 132 |
| Interferon-gamma-mediated signaling pathway | 264 |
| Interspecies interaction between organisms | 817 |
| Leukocyte tethering or rolling | 56 |
| Membrane to membrane docking | 38 |
| Positive regulation of T cell proliferation | 211 |
| Regulation of immune response | 318 |
Biological process
| Name | # of Products |
|---|---|
| Acute inflammatory response | 17 |
| Aging | 124 |
| B cell differentiation | 46 |
| Cell adhesion | 446 |
| Chorio-allantoic fusion | 10 |
| Chronic inflammatory response | 9 |
| Cytokine-mediated signaling pathway | 229 |
| Embryonic placenta morphogenesis | 7 |
| Heart development | 186 |
| Heterophilic cell-cell adhesion | 30 |
| Interferon-gamma-mediated signaling pathway | 61 |
| Interspecies interaction between organisms | 281 |
| Leukocyte cell-cell adhesion | 48 |
| Leukocyte tethering or rolling | 15 |
| Membrane to membrane docking | 8 |
| Positive regulation of T cell proliferation | 93 |
| Regulation of immune response | 89 |
| Response to hypoxia | 205 |
| Response to ionizing radiation | 43 |
| Response to nutrient | 95 |
Cellular components
| Name | # of Products |
|---|---|
| Alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex | 4 |
| Apical part of cell | 64 |
| Cell surface | 369 |
| External side of plasma membrane | 261 |
| Extracellular space | 884 |
| Filopodium | 36 |
| Integral to membrane | 2793 |
| Microvillus | 39 |
| Plasma membrane | 2678 |
| Podosome | 5 |
| Sarcolemma | 57 |
Protein function
| Name | # of Products |
|---|---|
| Cell adhesion molecule binding | 203 |
| Integrin binding | 463 |
-

-
VCAM1 Antibody - C-terminal region (ARP74339_P050)Catalog #: ARP74339_P050Species Tested: HumanApplication: WBFormat: Liquid. Purified antibody supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% sucrose. -
VCAM1 ELISA Kit (Human) : 96 Wells (OKEH00233)Catalog #: OKEH00233Application: ELISA-SandwichKit Range: 0.156-10ng/mLSensitivity: 0.039 ng/mL -
VCAM1 ELISA Kit (Rat) (OKEH02979)Catalog #: OKEH02979Application: ELISA-SandwichKit Range: 0.312-20ng/mLSensitivity: 0.177 ng/mL -
AvivaBlot Femto ECL Reagent (OKCF00002)Catalog #: OKCF00002Application: WBFormat: LiquidSize: 250 mL


